Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead

29 Nov 2024

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Companies

Arrowhead Pharmaceuticals, Inc.

Sarepta Therapeutics, Inc.

Novartis AG

Kate Therapeutics, Inc.

Vyriad, Inc.

Ratio Therapeutics, Inc.

Schrodinger, Inc.

LINDIS Biotech GmbH

Fresenius Biotech GmbH

Lindy Biosciences

Swedish Orphan Biovitrum AB

Cullgen Inc.

Pulmatrix, Inc.

Entero Therapeutics, Inc.

Journey Therapeutics, Inc.

Flare Therapeutics Inc.

Roche Holding AG

AlloVir, Inc.

Genprex, Inc.

University of Michigan

Eton Pharmaceuticals, Inc.

Endo, Inc.

MC2 Therapeutics A/S

Nerviano Medical Sciences SRL

Ribon Therapeutics, Inc.

ARTBIO Inc.

3B Pharmaceuticals GmbH

Sanofi

Healx

Enveric Biosciences Inc.

MycoMedica Life Sciences, PBC

Paladin Pharma Inc.

ARS Pharmaceuticals, Inc.

ALK-Abello A/S

More from Deal Watch

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.